According to the Zhitong Finance App, Xintai Healthcare (02291) announced that on August 31, 2026, the company spent HK$2.8801 million to repurchase 210,000 shares at a repurchase price of HK$13.02-14.23 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.